Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice.

This study assesses if specially designed fluorescent liposomes can be used as contrast agent for near-infrared fluorescence (NIRF) optical imaging of cultured macrophages in vitro and for NIRF imaging of inflammatory processes, like edema, in an in vivo mouse model. Fluorescent liposomes are prepared by the film hydration and extrusion method using cholesterol, L-phosphatidylcholine, and the NIR fluorescent dye DY-676-C(18) ester. Photon correlation spectroscopy and flow cytometry reveal that fluorescent liposomes are structurally stable for up to 133 days. Distinct uptake/labeling of cultured murine J774 macrophages is demonstrated by confocal laser scanning microscopy (CLSM), flow cytometry, and macroscopic NIRF imaging system at wavelengths >670 nm. Moreover, CLSM analysis reveals fluorescence signals within intracellular compartments. Ear edema is induced in mice (n = 16) by subcutaneous injection of zymosan A. Whole-body NIRF imaging is performed after intravenous injection (0-24 h) of fluorescent liposomes (55 nmol dye per kg body weight). Distinctly higher fluorescence intensities (1613.6 +/- 61.7 a.u.) are detected at inflamed areas of diseased mice as compared to controls (892.8 +/- 19.4 a.u.). Furthermore, cell isolated from ear lavage reveals the presence of labeled F4/80 positive tissue macrophages. Taken together, the results indicate both that mouse macrophages labeled with fluorescent liposomes can be detected in vitro with fluoro-optical methods and that in vivo optical imaging of inflammatory processes with fluorescent liposomes as contrast agent is feasible. Possibly, early stages of other inflammatory diseases could also be detected by the proposed diagnostic tool in the long term.

[1]  W. Kaiser,et al.  Diagnosis of peritonitis using near-infrared optical imaging of in vivo labeled monocytes-macrophages. , 2006, Journal of biomedical optics.

[2]  Anna Moore,et al.  In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy , 2006, International journal of cancer.

[3]  P. Jakob,et al.  Assessment of Cardiovascular Apoptosis in the Isolated Rat Heart by Magnetic Resonance Molecular Imaging , 2006, Molecular imaging.

[4]  Klaas Nicolay,et al.  Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging , 2006, NMR in biomedicine.

[5]  R. Weissleder,et al.  Particularities of the vasculature can promote the organ specificity of autoimmune attack , 2006, Nature Immunology.

[6]  Klaas Nicolay,et al.  Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.

[7]  P. van Hoogevest,et al.  Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  G. Storm,et al.  Liposomes in the treatment of inflammatory disorders , 2005, Expert opinion on drug delivery.

[9]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[10]  Britton Chance,et al.  Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Cailhier,et al.  Conditional Macrophage Ablation Demonstrates That Resident Macrophages Initiate Acute Peritoneal Inflammation1 , 2005, The Journal of Immunology.

[12]  Daniel L. Farkas,et al.  Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies , 1995, Cancer Immunology, Immunotherapy.

[13]  K. Török,et al.  A new assay for antiphlogistic activity: Zymosan-induced mouse ear inflammation , 1993, Agents and Actions.

[14]  W. Kaiser,et al.  Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells , 2004, European Radiology.

[15]  J. Debatin,et al.  [Magnetosomes as biological model for iron binding: relaxivity determination with MRI]. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[16]  P. Reimer,et al.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.

[17]  M. Pawlikowski,et al.  Anti-Inflammatory Effects of Somatostatin Analogs on Zymosan-Induced Earlobe Inflammation in Mice: Comparison with Dexamethasone and Ketoprofen , 2001, Neuroimmunomodulation.

[18]  J. Zasadzinski,et al.  Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants. , 1989, Science.

[19]  G. Gregoriadis,et al.  Preparation of liposomes containing factor VIII for oral treatment of haemophilia. , 1984, Journal of microencapsulation.

[20]  G. Poste,et al.  Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[22]  G. R. Bartlett Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.